When many cancers advance, spread and reoccur, checkpoint inhibitors can help keep difficult tumors at bay. These antibody-based immunotherapies can restore the body’s ability to recognize and ...

The FDA’s harsh stance against Tyvyt shows it’s serious about improving diversity in clinical trials, which is effectively erecting a major roadblock for many Chinese companies seeking U.S. expansions ...